Lorraine Chantrill Asia Pacific Neuroendocrine Tumour Society 2018

Abstracts this author is presenting:

• AGITG NABNEC:  A Randomised Phase II Study of Nab-Paclitaxel In Combination With Carboplatin As First Line Treatment Of Gastrointestinal Neuroendocrine Carcinomas — Afternoon Tea and Poster Session 2 (Evens)